TrialEuropean journal of cancer (Oxford, England : 1990)2011

Zoledronic acid preserves bone mineral density in premenopausal women who develop ovarian failure due to adjuvant chemotherapy: final results from CALGB trial 79809.

C L Shapiro et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.